Healthcare Stocks

GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

 GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

Highlights  The UK-based GlaxoSmithKline has received initial approval from the UK regulator for its sotrovimab, a monoclonal antibody, which could be effective against Omicron variant. The UK pharmaceutical industry received a significant...

Read More...
Oxford Covid-19 vaccine faces questions after dosing error

Oxford Covid-19 vaccine faces questions after dosing error

Though the recent back-to-back advancements in the development of a vaccine seemed to have enhanced the visibility of a silver lining in the fight against Covid-19 (SARS-CoV-2) virus, the hope of getting a clinically-approved vaccine remains bleak un...

Read More...
Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceuticals (NASDAQ: ICPT), Teva Pharmaceutical (NYSE: TEVA)

Pharma Stocks in Focus: Novartis (NYSE: NVS), Intercept Pharmaceuticals (NASDAQ: ICPT), Teva Pharmaceutical (NYSE: TEVA)

The pharmaceuticals industry has also been gripped by the aftereffects of coronavirus pandemic as even the pharma shares representing some of the major corporations like Novartis AG (NYSE: NVS), Intercept Pharmaceuticals Inc (NASDAQ: ICPT) have been ...

Read More...
COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency in Late-Stage Trials

COVID-19: AstraZeneca-Oxford’s Vaccine Shows 70 Per Cent Efficiency in Late-Stage Trials

Summary AstraZeneca said the Covid-19 vaccination, which the firm has been developing along with Oxford University, has shown a 70 per cent efficacy AstraZeneca CEO Pascal Soriot said the results are positive and show that it is highly effectiv...

Read More...
Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approval

Pfizer Covid-19 Vaccine Is World's First To Seek Emergency US Approval

  Pfizer and its partner BioNTech have submitted their report seeking early approvals from FDA for its Covid-19 vaccine The company has also started with its submissions in other countries such as Australia, Canada, Europe, Japan and the UK ...

Read More...
Pfizer-BioNTech vaccine to face stiff competition despite high success rate in trials

Pfizer-BioNTech vaccine to face stiff competition despite high success rate in trials

Summary The vaccine candidate was found to be 90 per cent efficient in preventing Covid-19 infection, making it one of the most effective against the virus. The vaccine, however, is not going to be available for at least a few months before the...

Read More...
Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results

Pfizer and BioNTech Skyrocket on Covid-19 Vaccine Results

Stock markets across the world witnessed a sharp uptick on Monday after initial data of a clinical trial showed that Pfizer and BioNTech’s vaccine candidate was more than 90 per cent effective in preventing COVID-19. Shares of both the pharm...

Read More...
GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments

GE Healthcare in partnership with GenesisCare to deliver improved Cancer and Cardiovascular treatments

GE Healthcare is the healthcare division of the American multinational conglomerate, General Electric (NYSE: GE). The division alone is valued at US$16.7 billion and provides medical technology and related digital solutions on a global scale. ...

Read More...
Arix Bioscience plc’s VelosBio to be acquired by Merck

Arix Bioscience plc’s VelosBio to be acquired by Merck

Summary NYSE listed Merck acquired VelosBio, a portfolio company of Arix Bioscience for US$2.75 billion Arix’s investment in VelosBio grew by 12 times Merck acquired VelosBio to bolster its oncology pipeline The global venture capit...

Read More...
TFF Pharmaceuticals releases results for Q3 2020

TFF Pharmaceuticals releases results for Q3 2020

Summary TFF Pharmaceuticals Inc. was incorporated in 2018 as a clinical-stage biopharmaceutical company The company’s patented technology platform, Thin Film Freezing, or TFF helps it in developing and commercializing innovative drug prod...

Read More...
How are these two AIM stocks performing: LiDCO Group Plc and TomCo Energy Plc?

How are these two AIM stocks performing: LiDCO Group Plc and TomCo Energy Plc?

Summary LiDCO Group Plc witnessed sales growth of 75% year-on-year during H1 FY21. The Company is getting acquired by Masimo Corporation. TomCo Energy Plc's POSP is expected to be operational by November 2020. The estimated capital cost for a...

Read More...